How Does It Work?
Kriya Biosciences’ APERI drug delivery technology is based on our patent-pending drug permeation enhancer, AP09. APERI permeation enhancers are smart tight junction modulators capable of facilitating enhanced absorption of co-administered therapies.
BIOAVAILABILITY
NON INVASIVE
MAXIMUM SAFETY
The Advantages
Broad range of therapeutic entities
High predictability and safety
Stand alone permeation approach
Adaptability towards formulation
Ease of manufacture
Broad range of therapeutic entities
High predictability and safety
Stand alone permeation approach
Adaptability towards formulation
Ease of manufacture
Key Differentiators That Make Us Unique
Being able to replace current intra-vitreal injection with eye drops represents a game changer for AMD treatment, a tremendous improvement of patient compliance, and a severe relief on health care costs. Our smart permeation enhancers posses the following attributes:
Fast-onset of permeation enhancement
Short time of action
Target-specific
Exerting a reversible effect on permeability
Non-toxic for short and long-term use
High translational capability towards the clinic
Fast-onset of permeation enhancement
Short time of action
Target-specific
Exerting a reversible effect on permeability
Non-toxic for short and long-term use
High translational capability towards the clinic
GET IN TOUCH
If you have a project idea or simply like to learn more about us, just send us an e-mail. No matter the subject, you will hear from us quickly